Functional analyses for transmembrane TNF-alpha

跨膜 TNF-α 的功能分析

基本信息

  • 批准号:
    17591048
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

TNF-alpha antagonists are the center of attention for their dramatic clinical efficacy in active chronic inflammatory diseases. In rheumatoid arthritis, both infliximab (chimeric anti-TNF-alpha antibody), adalimumab (humanized anti-TNF-alpha antibody) and etanercept (p75 TNF-alpha receptor fusion protein) are highly effective, while in Crohn's disease, only infliximab and adalimumab can induce clinical remission. As the differential clinical efficacy was likely to be caused by biological effects other than mere neutralization of soluble TNF-alpha, we here investigated reverse signaling through transmembrane TNF-alpha. mTNF induced by infliximab was analysed by cDNA array in the assay system using mTNF-expressing Jurkat T cells.Cytoplasmic serine residues at positions 2, 5 and 27 of mTNF were sequentially substituted to alanine by site-directed mutagenesis. Infliximab-induced apoptosis and cell cycle arrest were completely abrogated by substitution of all of these three cytoplasmic serine residues. In this study, we revealed that novel biological effects induced by infliximab and etanercept were mediated by reverse signaling of mTNF, which might explain the differential clinical efficacy of these anti-TNF-alpha. agents. We also clarified that cytoplasmic serine residues were critical for the signal transduction through mTNF.
TNF-α拮抗剂因其在活动性慢性炎性疾病中的显著临床疗效而成为关注的中心。在类风湿性关节炎中,英夫利西单抗(嵌合抗TNF-α抗体)、阿达木单抗(人源化抗TNF-α抗体)和依那西普(p75 TNF-α受体融合蛋白)均高度有效,而在克罗恩病中,只有英夫利西单抗和阿达木单抗可诱导临床缓解。由于不同的临床疗效可能是由生物学效应引起的,而不仅仅是可溶性TNF-α的中和,因此我们在此研究了通过跨膜TNF-α的反向信号传导。用cDNA芯片分析了英夫利西单抗诱导的mTNF,并将mTNF的2、5、27位丝氨酸突变为丙氨酸。英夫利昔单抗诱导的细胞凋亡和细胞周期停滞完全废除了所有这三个细胞质丝氨酸残基的取代。在这项研究中,我们发现英夫利西单抗和依那西普诱导的新的生物学效应是由mTNF的反向信号传导介导的,这可能解释了这些抗TNF-α的差异临床疗效。剂.我们还阐明了细胞质丝氨酸残基是通过mTNF的信号转导的关键。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus eryhtematosus
系统性红斑狼疮外周B淋巴细胞白细胞介素21受体表达降低
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    渡邊 浩;土橋佳子;Mitoma H Horiuchi T et al.
  • 通讯作者:
    Mitoma H Horiuchi T et al.
Molecular analysis of a novel hereditary C3 deficienc with systemic lupus erythematosus
一种新型遗传性 C3 缺乏症系统性红斑狼疮的分子分析
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tsukamoto H;Horiuchi T et al.
  • 通讯作者:
    Horiuchi T et al.
A phaseI-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease
自体外周血干细胞移植治疗难治性自身免疫性疾病的I-II期试验
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tsukamoto H;Nagafuji K;Horiuchi T;et. al.
  • 通讯作者:
    et. al.
Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT
  • DOI:
    10.1038/sj.gene.6364165
  • 发表时间:
    2005-03-01
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Horiuchi, T;Gondo, H;Harada, M
  • 通讯作者:
    Harada, M
Smoking, drinking, sleeping habits and other lifestyle factors and the risk of systemic lupus erythematosus (SLE) in Japanese females : findings from the KYSS study
日本女性吸烟、饮酒、睡眠习惯和其他生活方式因素与系统性红斑狼疮 (SLE) 的风险:KYSS 研究的结果
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Washio M;Horiuchi T;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HORIUCHI Takahiko其他文献

HORIUCHI Takahiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HORIUCHI Takahiko', 18)}}的其他基金

Clarification of the mechanisms of intracellular trafficking of TNF
阐明 TNF 细胞内运输机制
  • 批准号:
    23591464
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immunological function of transmembrane TNF-alpha
跨膜TNF-α的免疫功能
  • 批准号:
    20591172
  • 财政年份:
    2008
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the function of membrane TNF-α
膜TNF-α的功能分析
  • 批准号:
    14570418
  • 财政年份:
    2002
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of membrane TNF-α
膜TNF-α的功能分析
  • 批准号:
    12670429
  • 财政年份:
    2000
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of membrane TNF-α on activated T cells
膜TNF-α对活化T细胞的功能分析
  • 批准号:
    10670417
  • 财政年份:
    1998
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biological activity of complement fragment Ba
补体片段Ba的生物活性
  • 批准号:
    08670522
  • 财政年份:
    1996
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Distributed Network Meta-Analysis of Multi-Provincial Data to Evaluate Temporal Trends and the Impact of Anti-TNF Therapy on the Risks of Inflammatory Bowel Diseases-Associated Cancers
多省数据的分布式网络荟萃分析,以评估时间趋势以及抗 TNF 治疗对炎症性肠病相关癌症风险的影响
  • 批准号:
    421818
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
The microbiota in inflammatory bowel disease with resistance to anti-TNF therapy.
炎症性肠病中的微生物群对抗 TNF 疗法具有抵抗力。
  • 批准号:
    23590948
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
类风湿性关节炎抗 TNF 治疗反应的遗传预测因素
  • 批准号:
    8293200
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
类风湿性关节炎抗 TNF 治疗反应的遗传预测因素
  • 批准号:
    8514634
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
类风湿性关节炎抗 TNF 治疗反应的遗传预测因素
  • 批准号:
    8321217
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
类风湿性关节炎抗 TNF 治疗反应的遗传预测因素
  • 批准号:
    7868547
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
类风湿性关节炎抗 TNF 治疗反应的遗传预测因素
  • 批准号:
    8691893
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
类风湿性关节炎抗 TNF 治疗反应的遗传预测因素
  • 批准号:
    8101333
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
The influence of anti-TNF therapy on quality of life in patients with Crohn's Disease
抗TNF治疗对克罗恩病患者生活质量的影响
  • 批准号:
    22592473
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Interplay between intestinal microbiome and multimodal MRI brain biosignatures for prediction of response to anti-TNF therapy in ulcerative colitis
肠道微生物组与多模态 MRI 脑生物特征之间的相互作用预测溃疡性结肠炎抗 TNF 治疗的反应
  • 批准号:
    516215273
  • 财政年份:
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Clinical Research Units
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了